These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 25145330
1. Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study. Khatri N, Baradia D, Vhora I, Rathi M, Misra A. AAPS PharmSciTech; 2014 Dec; 15(6):1630-43. PubMed ID: 25145330 [Abstract] [Full Text] [Related]
2. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes. Hattori Y, Nakamura A, Arai S, Kawano K, Maitani Y, Yonemochi E. J Liposome Res; 2015 Dec; 25(4):279-86. PubMed ID: 25543847 [Abstract] [Full Text] [Related]
3. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes. Hattori Y, Machida Y, Honda M, Takeuchi N, Yoshiike Y, Ohno H, Onishi H. J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333 [Abstract] [Full Text] [Related]
4. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Ramezani M, Khoshhamdam M, Dehshahri A, Malaekeh-Nikouei B. Colloids Surf B Biointerfaces; 2009 Aug 01; 72(1):1-5. PubMed ID: 19395245 [Abstract] [Full Text] [Related]
8. Effect of the combination of cationic lipid and phospholipid on gene-knockdown using siRNA lipoplexes in breast tumor cells and mouse lungs. Hattori Y, Tang M, Aoki A, Ezaki M, Sakai H, Ozaki KI. Mol Med Rep; 2023 Oct 01; 28(4):. PubMed ID: 37594053 [Abstract] [Full Text] [Related]
11. cRGD grafted siRNA nano-constructs for chemosensitization of gemcitabine hydrochloride in lung cancer treatment. Khatri N, Rathi M, Baradia D, Misra A. Pharm Res; 2015 Mar 01; 32(3):806-18. PubMed ID: 24792823 [Abstract] [Full Text] [Related]
12. cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells. Khatri N, Baradia D, Vhora I, Rathi M, Misra A. J Control Release; 2014 May 28; 182():45-57. PubMed ID: 24631861 [Abstract] [Full Text] [Related]
13. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity. Belletti D, Tosi G, Forni F, Lagreca I, Barozzi P, Pederzoli F, Vandelli MA, Riva G, Luppi M, Ruozi B. Eur J Pharm Biopharm; 2016 Feb 28; 99():7-17. PubMed ID: 26625717 [Abstract] [Full Text] [Related]
16. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules. Herringson TP, Altin JG. J Control Release; 2009 Nov 03; 139(3):229-38. PubMed ID: 19595724 [Abstract] [Full Text] [Related]
17. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Kim HK, Davaa E, Myung CS, Park JS. Int J Pharm; 2010 Jun 15; 392(1-2):141-7. PubMed ID: 20347025 [Abstract] [Full Text] [Related]